BESSEMER GROUP INC

Position in ACAD — Acadia Pharmaceuticals Inc

CIK 1054074 WOODBRIDGE, NJ

Position in ACAD

as of Mar 31, 2026 · filed May 6, 2026 Compact

Position Value

$3,350,084

+$3,331,148 QoQ

Shares Held

150,498

+21126.8% QoQ

Ownership

0.088%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2020

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

BESSEMER GROUP INC holds $174,164,737 across 88 Biotechnology names. ACAD ranks #17 (1.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	64,251	$46,919,290
2	LGND	Ligand Pharmaceuticals Inc	107,859	$21,534,046
3	TNGX	Tango Therapeutics, Inc.	708,398	$14,819,686
4	MAZE	Maze Therapeutics, Inc.	481,790	$14,381,431
5	PTGX	Protagonist Therapeutics, Inc	54,178	$5,710,360
6	KRYS	Krystal Biotech, Inc.	20,285	$5,240,020
7	BMRN	Biomarin Pharmaceutical Inc	89,439	$5,052,409
8	ARWR	Arrowhead Pharmaceuticals, Inc.	79,140	$4,962,077

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,350,084	150,498	+21126.8%	Shares	Defined	2026-05-06
2025-12-31	$18,936	709	+18.4%	Shares	Defined	2026-02-05
2025-09-30	$12,782	599	+68.7%	Shares	Defined	2025-11-05
2025-06-30	$7,657	355	-27.6%	Shares	Defined	2025-08-01
2025-03-31	$8,138	490	+553.3%	Shares	Defined	2025-04-23
2024-09-30	$1,153	75	-60.7%	Shares	Defined	2024-11-12
2022-03-31	$4,626	191	0.0%	Shares	Defined	2022-05-12
2021-12-31	$4,457	191	0.0%	Shares	Defined	2022-01-27
2021-09-30	$3,172	191	0.0%	Shares	Defined	2021-11-12
2021-06-30	$4,658	191	0.0%	Shares	Defined	2021-08-06
2021-03-31	$4,927	191	—	Shares	Defined	2021-05-13
2020-12-31	$0	0	—	Shares	Defined	2021-02-09
No filing history on record for this holder in this stock.